open access
Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis
, 2, 3, 4, 5, 2, 1
Affiliations- 1st Chair and Department of Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
- 3rd Chair and Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
- Department of Human Nutrition, School of Public Health in Bytom, Silesian Center of Heart Disease in Zabrze, Medical University of Silesia, Katowice, Poland
- Department of Biostatistics, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland
- 2nd Chair and Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
open access
Abstract
Background: Coronavirus disease 2019 (COVID-19) pandemic disorganised healthcare systems and has caused a reduction in the number of hospitalizations and procedures. Cardiac implantable electronic device (CIED) procedure rates and clinical characteristics of their recipients were compared in corresponding weeks of 2019 and 2020 were analyzed.
Methods: The database of the National Health Fund (NHF) in Poland was retrospectively analyzed. 3206 patients who underwent CIED implantation in the Silesia — a region in Southern Poland comprising an adult population of 3.8 million between 12th and 31st week of 2020. Patients were classified into groups: the recipient of an implantable cardioverter-defibrillator or cardiac resynchronization therapy group (ICD/CRT) or pacemaker group (PM).
Results: During the pandemic a reduction of 39.38% of implantations was observed compared to the same period in 2019 (1210 vs. 1996 patients) and had impacted both groups. Two phases lasting 10 weeks each could be distinguished: total lockdown (maximal reduction) and the recovery phase with growing numbers of procedures. Patient baseline characteristics (sex, age, comorbidities) who were implanted during the COVID-19 pandemic did not differ from the 2019 period. The rate of peri-procedural mortality was also similar.
Conclusions: During COVID-19 pandemic period a reduction in CIED implantations of all types was observed. Despite the decreased number of performed CIED implants, no differences in baseline patient characteristics were observed.
Abstract
Background: Coronavirus disease 2019 (COVID-19) pandemic disorganised healthcare systems and has caused a reduction in the number of hospitalizations and procedures. Cardiac implantable electronic device (CIED) procedure rates and clinical characteristics of their recipients were compared in corresponding weeks of 2019 and 2020 were analyzed.
Methods: The database of the National Health Fund (NHF) in Poland was retrospectively analyzed. 3206 patients who underwent CIED implantation in the Silesia — a region in Southern Poland comprising an adult population of 3.8 million between 12th and 31st week of 2020. Patients were classified into groups: the recipient of an implantable cardioverter-defibrillator or cardiac resynchronization therapy group (ICD/CRT) or pacemaker group (PM).
Results: During the pandemic a reduction of 39.38% of implantations was observed compared to the same period in 2019 (1210 vs. 1996 patients) and had impacted both groups. Two phases lasting 10 weeks each could be distinguished: total lockdown (maximal reduction) and the recovery phase with growing numbers of procedures. Patient baseline characteristics (sex, age, comorbidities) who were implanted during the COVID-19 pandemic did not differ from the 2019 period. The rate of peri-procedural mortality was also similar.
Conclusions: During COVID-19 pandemic period a reduction in CIED implantations of all types was observed. Despite the decreased number of performed CIED implants, no differences in baseline patient characteristics were observed.
Keywords
COVID-19, cardiac implantable electronic devices, pacemakers, implantable cardioverter-defibrillator, cardiac resynchronization therapy, pandemic
About this articleTitle
Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis
Journal
Issue
Article type
Original Article
Pages
27-32
Published online
2021-12-17
Page views
5399
Article views/downloads
764
DOI
Pubmed
Bibliographic record
Cardiol J 2022;29(1):27-32.
Keywords
COVID-19
cardiac implantable electronic devices
pacemakers
implantable cardioverter-defibrillator
cardiac resynchronization therapy
pandemic
Authors
Artur Filipecki
Michał Orszulak
Mateusz Tajstra
Oskar Kowalski
Michał Skrzypek
Zbigniew Kalarus
Mariusz Gąsior
Katarzyna Mizia-Stec
References (10)- Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. 2020; 17(9): e233–e241.
- Kempa M, Gułaj M, Farkowski MM, et al. Electrotherapy and electrophysiology procedures during the coronavirus disease 2019 pandemic: an opinion of the Heart Rhythm Section of the Polish Cardiac Society (with an update). Kardiol Pol. 2020; 78(5): 488–492.
- Gąsior M, Pres D, Wojakowski W, et al. Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database. Pol Arch Med Wewn. 2016; 126(10): 754–762.
- Migliore F, Zorzi A, Gregori D, et al. Urgent pacemaker implantation rates in the veneto region of italy after the COVID-19 outbreak. Circ Arrhythm Electrophysiol. 2020; 13(6): e008722.
- Gonzales-Luna AC, Torres-Valencia JO, Alarcón-Santos JE, et al. Impact of COVID-19 on pacemaker implant. J Arrhythm. 2020 [Epub ahead of print]; 36(5): 845–848.
- Marini M, Zilio F, Martin M, et al. COVID-19 pandemic and elderly: is the curtain dropped for urgent pacemaker implantations? Minerva Cardioangiol. 2020 [Epub ahead of print].
- Chew QH, Wei KC, Vasoo S, et al. Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic. Singapore Med J. 2020; 61(7): 350–356.
- De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol. 2020; 76(20): 2321–2330.
- Bollmann A, Pellissier V, Hohenstein S, et al. Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes. 2021; 7(4): e5–e6.
- Boriani G, Palmisano P, Guerra F, et al. Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med. 2020; 15(8): 1445–1456.
